ISSN: 0954-7894

Journal Home

Journal Guideline

Clinical and Experimental Allergy Q2 Unclaimed

Wiley-Blackwell Publishing Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical and Experimental Allergy is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 154. It has a price of 2600 €. It has an SJR impact factor of 1,462 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,462.

Clinical and Experimental Allergy focuses its scope in these topics and keywords: allergy, atopic, risk, cells, asthma, results, urticaria, prediction, association, eosinophilic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2)

Price

2600 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,462

SJR Impact factor

154

H Index

181

Total Docs (Last Year)

572

Total Docs (3 years)

6018

Total Refs

2029

Total Cites (3 years)

441

Citable Docs (3 years)

3,26

Cites/Doc (2 years)

33,25

Ref/Doc

Other journals with similar parameters

Cell Death Discovery Q2
International Reviews of Immunology Q2
Immunity and Ageing Q2
Mediators of Inflammation Q2
Genes and Immunity Q2

Compare this journals

Aims and Scope

Best articles by citations

Infection with the roundworm Toxocara canis leads to exacerbation of experimental allergic airway inflammation

Diagnosis of concomitant inducible laryngeal obstruction and asthma

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .